Kiers D - Search Results

1

Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion.

Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, Thomas C, Bourgeois T, Dejong CHC, Kox M, Hundscheid IHR, Khan NA, Mandard S, Deckert V, Pickkers P, Drucker DJ, Lagrost L, Grober J. Lebrun LJ, et al. Among authors: kiers d. Cell Rep. 2017 Oct 31;21(5):1160-1168. doi: 10.1016/j.celrep.2017.10.008. Cell Rep. 2017. PMID: 29091756 Free article.

2

The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options.

Postma N, Kiers D, Pickkers P. Postma N, et al. Among authors: kiers d. Int J Antimicrob Agents. 2015 Dec;46 Suppl 1:S47-50. doi: 10.1016/j.ijantimicag.2015.11.001. Epub 2015 Nov 3. Int J Antimicrob Agents. 2015. PMID: 26612229 Review.

3

Short-term hyperoxia does not exert immunologic effects during experimental murine and human endotoxemia.

Kiers D, Gerretsen J, Janssen E, John A, Groeneveld R, van der Hoeven JG, Scheffer GJ, Pickkers P, Kox M. Kiers D, et al. Sci Rep. 2015 Nov 30;5:17441. doi: 10.1038/srep17441. Sci Rep. 2015. PMID: 26616217 Free PMC article.

4

Reply to: Re: The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic options.

Postma N, Kiers D, Pickkers P. Postma N, et al. Among authors: kiers d. Int J Antimicrob Agents. 2016 Mar;47(3):243. doi: 10.1016/j.ijantimicag.2015.12.013. Epub 2016 Jan 21. Int J Antimicrob Agents. 2016. PMID: 26895607 No abstract available.

5

Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin.

Kiers D, Koch RM, Hamers L, Gerretsen J, Thijs EJ, van Ede L, Riksen NP, Kox M, Pickkers P. Kiers D, et al. Sci Rep. 2017 Jan 5;7:40149. doi: 10.1038/srep40149. Sci Rep. 2017. PMID: 28054645 Free PMC article.

6

Markers of Intestinal Damage and their Relation to Cytokine Levels in Cardiac Surgery Patients.

Habes QLM, Linssen V, Nooijen S, Kiers D, Gerretsen J, Pickkers P, Scheffer GJ, Kox M. Habes QLM, et al. Among authors: kiers d. Shock. 2017 Jun;47(6):709-714. doi: 10.1097/SHK.0000000000000803. Shock. 2017. PMID: 28505628

7

[No glucocorticoids for treatment of sepsis; unless…].

Kamps MJA, Kiers D, Pickkers P. Kamps MJA, et al. Among authors: kiers d. Ned Tijdschr Geneeskd. 2017;161:D1461. Ned Tijdschr Geneeskd. 2017. PMID: 28558852 Dutch.

8

LPS-Induced ex vivo Cytokine Production is Not Augmented in Patients with Von Hippel-Lindau Disease.

Kiers D, Timmers HJLM, Gerretsen J, Pickkers P, Kox M. Kiers D, et al. Scand J Immunol. 2017 Sep;86(3):179-180. doi: 10.1111/sji.12578. Scand J Immunol. 2017. PMID: 28675455 Free article. No abstract available.

9

A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia.

Kiers D, van der Heijden WA, van Ede L, Gerretsen J, de Mast Q, van der Ven AJ, El Messaoudi S, Rongen GA, Gomes M, Kox M, Pickkers P, Riksen NP. Kiers D, et al. Thromb Haemost. 2017 Aug 30;117(9):1798-1807. doi: 10.1160/TH16-10-0799. Epub 2017 Jul 6. Thromb Haemost. 2017. PMID: 28692111 Clinical Trial.

10

Short-Term Hypoxia Dampens Inflammation in vivo via Enhanced Adenosine Release and Adenosine 2B Receptor Stimulation.

Kiers D, Wielockx B, Peters E, van Eijk LT, Gerretsen J, John A, Janssen E, Groeneveld R, Peters M, Damen L, Meneses AM, Krüger A, Langereis JD, Zomer AL, Blackburn MR, Joosten LA, Netea MG, Riksen NP, van der Hoeven JG, Scheffer GJ, Eltzschig HK, Pickkers P, Kox M. Kiers D, et al. EBioMedicine. 2018 Jul;33:144-156. doi: 10.1016/j.ebiom.2018.06.021. Epub 2018 Jul 4. EBioMedicine. 2018. PMID: 29983349 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page